Sandoz sues FDA over delay in first biogeneric approval.
Fox
Jeffrey L
JL
D001709:Biotechnology / Q000331:legislation & jurisprudence*; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence* / Q000639:trends*; D016568:Drugs, Generic / Q000592:standards*; D019382:Human Growth Hormone / Q000627:therapeutic use; D007880:Legislation, Drug; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D016568:Drugs, Generic; D011994:Recombinant Proteins; D019382:Human Growth Hormone